Mid-Atlantic Division
CHTN OvCa2 - Ovarian Carcinoma Survey 2
TMA Map - Cancer type
TMA Map - Case ID
Tissue List
| TMA code | Diagnosis | Age | pT stage | Grade |
|---|---|---|---|---|
| SPC-1 | Serous papillary carcinoma | 62 | pT3c [IIIC] | high |
| SPC-2 | Serous papillary carcinoma | 64 | pT3b [IIIB] | high |
| SPC-3 | Serous papillary carcinoma | 64 | pT2a [IIA] | high |
| SPC-4 | Serous papillary carcinoma | 62 | pT3c [IIIC] | high |
| SPC-5 | Serous papillary carcinoma | 65 | pT3a [IIIC] | high |
| SPC-6 | Serous papillary carcinoma | 74 | pT3c [IIIC] | high |
| SPC-7 | Serous papillary carcinoma | 42 | pT2a [IIA] | high |
| SPC-8 | Serous papillary carcinoma | 45 | pT3c [IIIC] | high |
| SPC-9 | Serous papillary carcinoma | 52 | pT3c [IIIC] | high |
| SPC-10 | Serous papillary carcinoma | 66 | pT3c [IIIC] | high |
| SPC-11 | Serous papillary carcinoma | 64 | pT3b [IIIB] | high |
| SPC-121 | Serous papillary carcinoma | 71 | pT3c [IIIC] | high |
| EAC-1 | Endometriod adenocarcinoma | 58 | pT1c [IC] | moderate |
| EAC-2 | Endometriod adenocarcinoma | 59 | pT2c [IIC] | moderate |
| EAC-3 | Endometriod adenocarcinoma | 67 | pT1a [IA] | low |
| EAC-4 | Endometriod adenocarcinoma | 52 | pT1c [IC] | low |
| EAC-5 | Endometriod adenocarcinoma | 51 | pT1c [IC] | low |
| EAC-6 | Endometriod adenocarcinoma | 52 | pT2b [IIB] | high |
| EAC-7 | Endometriod adenocarcinoma | 65 | pT1a [IA] | high |
| EAC-8 | Endometriod adenocarcinoma | 42 | pT3c [IIIC] | high |
| EAC-9 | Endometriod adenocarcinoma | 49 | pT1a | high |
| EAC-10 | Endometriod adenocarcinoma | 76 | pT1c | moderate |
| EAC-11 | Endometriod adenocarcinoma | 70 | pT1a | moderate |
| EAC-121 | Endometriod adenocarcinoma | 83 | pT1c | low |
| CCC-1 | Clear cell carcinoma | 62 | pT1c [IC] | high |
| CCC-2 | Clear cell carcinoma | 77 | pT3a [IIIA] | high |
| CCC-3 | Clear cell carcinoma | 73 | pT2C [IIC] | high |
| CCC-4 | Clear cell carcinoma | 72 | pT1a [IA] | high |
| CCC-5 | Clear cell carcinoma | 42 | pT3a [IIIA] | high |
| CCC-6 | Clear cell carcinoma | 27 | pT3c [IIIC] | high |
| CCC-7 | Clear cell carcinoma | 46 | pT3c [IIIC] | high |
| CCC-8 | Clear cell carcinoma | 68 | pT3a [IIIA] | high |
| CCC-9 | Clear cell carcinoma | 88 | pT1c [IC] | high |
| CCC-10 | Clear cell carcinoma | 39 | pT1a [IA] | high |
| CCC-11 | Clear cell carcinoma | 76 | pT2c [IIC] | high |
| CCC-12 | Clear cell carcinoma | 50 | pT1c | high |
| MAC-1 | Mucinous adenocarcinoma | 20 | pT1a | low |
| MAC-2 | Mucinous adenocarcinoma | 63 | pT1a | high |
| MAC-31 | Mucinous adenocarcinoma | 57 | pT1a | high |
| MAC-4 | Mucinous adenocarcinoma | 40 | pT1a | high |
| MAC-5 | Mucinous adenocarcinoma | 69 | pT3a | not assigned |
| MAC-6 | Mucinous adenocarcinoma | 43 | pT1a | low |
| MAC-7 | Mucinous adenocarcinoma | 29 | pT2b | high |
| MAC-8 | Mucinous adenocarcinoma | 62 | pT3c | moderate |
| MAC-9 | Mucinous adenocarcinoma | 63 | pT1a | low |
| MAC-10 | Mucinous adenocarcinoma | 66 | n/a | moderate |
| SBT-1 | Serous borderline tumor | 57 | pT1c | low |
| SBT-2 | Serous borderline tumor | 72 | pT1a | low |
| SBT-3 | Serous borderline tumor | 46 | pT1c | low |
| SBT-4 | Serous borderline tumor | 46 | pT3a | low |
| SBT-5 | Serous borderline tumor | 49 | pT1c | low |
| SBT-6 | Serous borderline tumor | 39 | pT1C | low |
| MBT-1 | Mucinous borderline tumor | 70 | pT1C | low |
| MBT-2 | Mucinous borderline tumor | 50 | pT1c | low |
| MBT-3 | Mucinous borderline tumor | 13 | n/a | low |
| MBT-4 | Mucinous borderline tumor | 67 | pT1c | low |
| MBT-5 | Mucinous borderline tumor | 54 | pT1a | low |
| MBT-6 | Mucinous borderline tumor | 49 | pT1a | low |
| NPE-1 | Normal proliferative endometrium | 57 | N/A | N/A |
| NPE-2 | Normal proliferative endometrium | 43 | N/A | N/A |
| NPE-3 | Normal proliferative endometrium | 43 | N/A | N/A |
| NPE-4 | Normal proliferative endometrium | 46 | N/A | N/A |
| NPE-5 | Normal proliferative endometrium | 41 | N/A | N/A |
| NPE-6 | Normal proliferative endometrium | 57 | N/A | N/A |
| NFT-1 | Normal fallopian tube fimbriae | 67 | N/A | N/A |
| NFT-2 | Normal fallopian tube fimbriae | 61 | N/A | N/A |
| NFT-31 | Normal fallopian tube fimbriae | 47 | N/A | N/A |
| NFT-4 | Normal fallopian tube fimbriae | 61 | N/A | N/A |
| NFT-5 | Normal fallopian tube fimbriae | 75 | N/A | N/A |
| NFT-6 | Normal fallopian tube fimbriae | 64 | N/A | N/A |
| SCA-1 | Serous cystadenoma | 50 | N/A | N/A |
| SCA-2 | Serous cystadenoma | 71 | N/A | N/A |
| SCA-31 | Serous cystadenoma | 76 | N/A | N/A |
| SCA-41 | Serous cystadenoma | 53 | N/A | N/A |
| SCA-5 | Serous cystadenoma | 46 | N/A | N/A |
| SCA-61 | Serous cystadenoma | 74 | N/A | N/A |
| MCA-1 | Mucinous cystadenoma | 51 | N/A | N/A |
| MCA-2 | Mucinous cystadenoma | 42 | N/A | N/A |
| MCA-3 | Mucinous cystadenoma | 60 | N/A | N/A |
| MCA-4 | Mucinous cystadenoma | 76 | N/A | N/A |
| MCA-5 | Mucinous cystadenoma | 42 | N/A | N/A |
| MCA-6 | Mucinous cystadenoma | 25 | N/A | N/A |
1These cases sampled with additional cores due to difficult target tissue.